Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
556.30
-18.20 (-3.17%)
Aug 14, 2025, 5:24 PM IDT

Enlivex Therapeutics Market Cap

Enlivex Therapeutics has a market cap or net worth of 125.05 million as of August 14, 2025. Its market cap has increased by 17.57% in one year.

Market Cap
125.05M
Enterprise Value
57.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
556.30

Market Cap Chart

Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 125.05M, a decrease of -66.02%. That is a compound annual growth rate of -15.55%.

History

DateMarket Cap% Change
Aug 13, 2025125.05M33.45%
Dec 31, 202493.71M-48.18%
Dec 29, 2023180.84M-29.06%
Dec 30, 2022254.92M-28.46%
Dec 31, 2021356.33M-8.65%
Dec 31, 2020390.07M30.23%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Teva Pharmaceutical Industries 64.35B
Danel (Adir Yeoshua) 2.50B
Kamada 1.44B
Bait Bakfar 1.05B
SofWave Medical 977.04M
BrainsWay 772.64M
Novolog (Pharm-Up 1966) 709.61M
Ilex Medical 675.99M
Market Cap Rankings